These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 4480369)

  • 21. [Preliminary note on histologic changes induced by a new synthetic gestagen (19-nor-17-alpha-hydroxyprogesterone capronate) on adenocarcinoma of the endometrium].
    Vecchione A; Ruozi Berretta L
    Riv Anat Patol Oncol; 1968; 33():431-60. PubMed ID: 5760166
    [No Abstract]   [Full Text] [Related]  

  • 22. [Effect of gestagen on uterine adenocarcinoma of the endometrium in the human, with special reference to electron microscope study].
    Hayakawa K; Okudaira Y; Nasu K; Iijima H; Taki I
    Nihon Sanka Fujinka Gakkai Zasshi; 1968 Nov; 20(11):1528-9. PubMed ID: 5752842
    [No Abstract]   [Full Text] [Related]  

  • 23. Proceedings: Vaginal cytologic evaluation as a predictive test on hormone dependency and responsiveness to progestogens of endometrial adenocarcinoma.
    Ide P; Bonte J
    Br J Cancer; 1974 Aug; 30(2):175. PubMed ID: 4419502
    [No Abstract]   [Full Text] [Related]  

  • 24. Chemotherapy of advanced carcinoma of the prostate with 5-fluorouracil, cyclophosphamide and adriamycin.
    Merrin C; Etra W; Wajsman Z; Baumgartner G; Murphy G
    J Urol; 1976 Jan; 115(1):86-8. PubMed ID: 1107604
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oral progestin therapy for metastatic adenocarcinoma of the endometrium.
    Puckett TG; Merrill JA
    J Okla State Med Assoc; 1967 Sep; 60(9):506-11. PubMed ID: 6076025
    [No Abstract]   [Full Text] [Related]  

  • 26. Adjuvant progestogen therapy in the primary definitive treatment of endometrial cancer.
    Lewis GC; Slack NH; Mortel R; Bross ID
    Gynecol Oncol; 1974 Aug; 2(2-3):368-76. PubMed ID: 4616883
    [No Abstract]   [Full Text] [Related]  

  • 27. Combination of progestogen therapy with the conventional treatment of endometrial carcinoma.
    Luukkainen T; Karjalainen O
    Bull Schweiz Akad Med Wiss; 1970 Oct; 25(4-6):581-5. PubMed ID: 5510182
    [No Abstract]   [Full Text] [Related]  

  • 28. Progestins in the treatment of patients with endometrial adenocarcinoma.
    Smith JP; Rutledge F; Soffar SW
    Am J Obstet Gynecol; 1966 Apr; 94(7):977-84. PubMed ID: 5910365
    [No Abstract]   [Full Text] [Related]  

  • 29. Use of cisplatin, doxorubicin, and cyclophosphamide to treat advanced and recurrent adenocarcinoma of the endometrium.
    Hancock KC; Freedman RS; Edwards CL; Rutledge FN
    Cancer Treat Rep; 1986 Jun; 70(6):789-91. PubMed ID: 3731140
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adjuvant chemotherapy for cancer of the corpus uteri. Preliminary report.
    Lewis GC; Nadler SH; Bross ID; Slack NH
    Obstet Gynecol; 1967 Jun; 29(6):797-802. PubMed ID: 5338150
    [No Abstract]   [Full Text] [Related]  

  • 31. [The modern organ- and function-sparing surgical treatment in oncology].
    Semiglazov VF; Maksimov SIa; Semiglazov VV; Kosnikov AG
    Vestn Ross Akad Med Nauk; 2003; (10):34-8. PubMed ID: 14598509
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The treatment of advanced endometrial cancer with hydroxyprogesterone caproate.
    Reifenstein EC
    Gynecol Oncol; 1974 Aug; 2(2-3):377-414. PubMed ID: 4616884
    [No Abstract]   [Full Text] [Related]  

  • 33. [Role of progestatives in the treatment of cancer of the endometrium].
    Binard JM
    Brux Med; 1970 Oct; 50(10):713-8. PubMed ID: 5475457
    [No Abstract]   [Full Text] [Related]  

  • 34. [Treatment with high doses of progestational agents in endometrial adenocarcinoma].
    Goisis M; Servida E; Goisis F
    Minerva Ginecol; 1976 Jan; 28(1):87-96. PubMed ID: 1256709
    [No Abstract]   [Full Text] [Related]  

  • 35. Clinical use of progestins in the menopausal patient: dosage and duration.
    Gambrell RD
    J Reprod Med; 1982 Aug; 27(8 Suppl):531-8. PubMed ID: 7131446
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Doxorubicin hydrochloride, cyclophosphamide, and 5-fluorouracil combination in advanced prostate and transitional cell carcinoma.
    Collier D; Soloway MS
    Urology; 1976 Nov; 8(5):459-64. PubMed ID: 982733
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of recurrent and metastatic endometrial cancer with cisplatin, doxorubicin, cyclophosphamide, and megestrol acetate.
    Hoffman MS; Roberts WS; Cavanagh D; Praphat H; Solomon P; Lyman GH
    Gynecol Oncol; 1989 Oct; 35(1):75-7. PubMed ID: 2477317
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of cytostatic activities of cytembena and cyclophosphamide during short-term administration to women with gynaecological carcinoma.
    Skoda V; Jandová A; Novotná J
    Neoplasma; 1970; 17(2):175-81. PubMed ID: 5269150
    [No Abstract]   [Full Text] [Related]  

  • 39. Megestrol acetate in the management of advanced endometrial carcinoma.
    Wait RB
    Obstet Gynecol; 1973 Jan; 41(1):129-36. PubMed ID: 4682608
    [No Abstract]   [Full Text] [Related]  

  • 40. The use of progestational agents in the treatment of carcinoma of the endometrium.
    McDuff HC; Barrall JH
    Trans N Engl Obstet Gynecol Soc; 1965; 19():75-89. PubMed ID: 5872595
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.